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Background: The Gambia Demographic and Health Survey 2013 data showed that up
to 63% of deliveries in the country occur in health facilities. Despite such a high rate,
there are few facility-based studies on delivery outcomes in the country. This analysis
ancillary to a randomized control trial describes occurrence of poor pregnancy outcomes
in a cohort of women and their infants delivering in a government health facility in
urban Gambia.
Methods: Using clinical information obtained during the trial, we calculated rates of poor
pregnancy outcomes including stillbirths, hospitalization and neonatal deaths. Logistic
regression was used to calculate odds ratio (OR) and 95% confidence interval (CI) in the
risk factors analysis.
Results: Between April 2013 and 2014, 829 mothers delivered 843 babies, including
13 stillbirths [15.4 (7.1–23.8)] per 1,000 births. Among 830 live born infants, 7.6%
(n = 63) required hospitalization during the 8-week follow-up period. Most of these
hospitalizations (74.6%) occurred during the early neonatal period (<7 days of life).
Severe clinical infections (i.e., sepsis, meningitis and pneumonia) (n = 27) were the most
common diagnoses, followed by birth asphyxia (n= 13), major congenital malformations
(n= 10), jaundice (n= 6) and low birth weight (n= 5). There were sixteen neonatal deaths,
most of which also occurred during the early neonatal period. Overall, neonatal mortality
rate (NMR) and perinatal mortality rate (PMR) were 19.3 (CI: 9.9–28.7) per 1,000 live births
and 26.1 (CI: 15.3–36.9) per 1,000 total births, respectively. Severe clinical infections and
birth asphyxia accounted for 37 and 31% of neonatal deaths, respectively. The risk of
hospitalization was higher among neonates with severe congenital malformations, low
birth weight, twin deliveries, and those born by cesarean section. Risk of mortality was
higher among neonates with severe congenital malformations and twin deliveries.
Conclusion: Neonatal hospitalization and deaths in our cohort were high. Although
vertical interventions may reduce specific causes of morbidity and mortality, data indicate
the need for a holistic approach to significantly improve the rates of poor pregnancy
outcomes. Critically, a focus on decreasing the high rate of stillbirths is warranted.
Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT01800942.
Keywords: stillbirth, neonatal mortality, congenital malformation, sepsis, birth asphyxia, hospitalization, The
Gambia
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INTRODUCTION
Newborn health is a global health priority due to unacceptable
high levels of morbidity and mortality in children <1 month old
(1). Almost half of deaths in children occur during the neonatal
period (2), and 3 out of 4 neonatal deaths occur within the first
week of life (3). While the decline in neonatal mortality has
consistently lagged behind that of infants and older children,
the number of stillbirths has reduced even more slowly over
the years (4). It is estimated that there are up to 2.6 million
stillbirths each year, with over 75% of deaths occurring during
labor, primarily in low income countries (4). Sub-Saharan Africa
(SSA) and Southern Asia both account for almost 80% of the
annual global burden of perinatal deaths (2).
Globally, the major causes of neonatal morbidity and
mortality are prematurity, intrapartum related complications,
severe infections and congenital malformations (5). The
distribution of cause of death differs throughout the neonatal
period (early vs. late neonatal period) and by neonatal mortality
rate (3). In general, infections and intrapartum-related events
account for a higher proportion of deaths in higher mortality
settings (3). Risk factors associated with poor pregnancy
outcomes include limited access to skilled care during delivery
and poor socio-economic conditions (6), both common in SSA,
where the poorest households carry the greatest burden (7, 8).
Poormaternal nutrition andmultiple-pregnancy, both associated
with prematurity and low birth weight, are also indirect causes
of poor pregnancy outcomes (9). Additionally, it is difficult to
accurately quantify the rates of poor outcomes in SSA, even
in health facilities, as death certificates are often not issued for
stillbirths, making it difficult to quantify the burden of stillbirths
in the region (4). For neonatal deaths outside of health facilities,
cause of death is mostly established by verbal autopsy, which can
be inaccurate (10). Despite this, and although the main cause of
neonatal death differs by country and geographical regions (7, 8),
many deaths can be prevented if the risk is recognized early to
implement appropriate treatment (11, 12).
The Sustainable Development Goal 3, Target 3.2 is to decrease
neonatal mortality to <12 per 100,000 live-births by 2030 in all
countries (13). In general, data on neonatal outcomes in West
Africa is scarce. In The Gambia, although the mortality rate for
under-5s has decreased by more than two-thirds in the last 10
years, reduction of the neonatal mortality rate has occurred at
a slower pace and recent data on the rate of stillbirths in the
country is not available (14). In this study, we assessed rates of
stillbirths, neonatal and perinatal morbidity and mortality rates
in a cohort of infants born to 829 mothers in a busy urban health
facility in western Gambia.Women were originally recruited into
a randomized control trial and were followed, with their children,




This is a secondary analysis of the PregnAnZI trial
(NCT01800942 at ClinicalTrials.gov), a phase-III, double-
blind, placebo-controlled individually randomized clinical trial
in which 829 women in labor were allocated to receive either
a single dose of oral azithromycin or placebo (ratio 1:1). The
study results showed that there were differences in bacterial
colonization and non-serious clinical conditions between
study arms. However, the study was not powered to determine
differences in severe neonatal morbidity and mortality, and
therefore, we have included the full trial cohort in our analysis
presented here (16).
Study Setting
The study was based at the Bundung Maternal and Child Health
Hospital, previously Jammeh Foundation for Peace (JFP) health
center, a government-run facility located in western Gambia that
manages up to 5,000 deliveries per year (16). The population of
the catchment area is representative of The Gambia and includes
all main ethnic groups. Illiteracy rates are high, up to 55% among
women (14). The level of consanguinity is moderately high at
∼30% frequency of first-cousinmarriages (17). The climate of the
area is typical of the sub-Sahel region (16).
Study Design and Participants
The trial recruited women aged 18–45 attending antenatal, natal
and postnatal care at the study health facility, and their children
(16). Women were excluded from participating in the trial if they
had an HIV infection, or a chronic or acute condition which
might interfere with the study as judged by the research clinicians
(15). Women were also excluded if they had a planned cesarean
section, known required referral, known multiple pregnancy,
known severe congenital malformation of the unborn baby,
intrauterine fetal death before randomization, known allergy
to macrolides and/or intake of antibiotics in the week before
randomization. Mothers who were planning to travel out of the
catchment area during the 2 month follow-up period were also
excluded (16).
Study Procedures
The field team conducted sensitization and consenting for
women during antenatal clinic visits. Women who presented at
the study health facility for delivery were screened to confirm
consent and ensure all eligibility criteria were met (16). If a
woman who had signed consent was still willing to participate
in the study, she was assigned a randomization number and
administered the trial investigational product. At the time of the
study, the health facility lacked the capacity to provide emergency
obstetric care, including surgical care. Women in need of an
emergency cesarean section were referred to the Edward Francis
Small Teaching Hospital in Banjul, ∼20 kilometers from the
study site (16). As per study procedures, stillbirth information
and birth weight were collected after delivery (16). A thorough
clinical assessment of the mother and the baby was carried out
by either the trial research clinician or pediatrician 4–24 h after
childbirth (15). Women and their babies were visited daily at
home by trained nurses for a week post-delivery. After this
period, mothers were scheduled to report to the study team at
the health facility between days 8 and 13, where a study clinician
or pediatrician carried out a thorough clinical assessment of the
mother/child pair (16). Field workers visited the mothers and
newborns each week for 8-weeks post-partum. Weekly active
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follow-up visits were complemented with passive follow-up visits
at the study health facility and the Clinical Services Department
at the Medical Research Council Unit The Gambia (16).
Adverse events were monitored and assessed throughout
the follow up period to evaluate safety of the intervention on
mothers and newborns (16). Diagnoses of serious infections,
perinatal asphyxia and congenital malformation among others
were primarily based on clinical judgment of the study clinician
and pediatrician (18).
Data Management and Statistical Analysis
Case report forms were reviewed for accuracy, consistency
and completeness before being entered in an OpenClinica
(www.openclinica.com) database. Consistency checks and data
validation were performed at regular intervals (16).
For this analysis, the neonatal period was defined as 0–56
days after delivery rather than the conventional definition of 0–
28 days, as per the study active follow-up period (19). The early
neonatal period was defined as 0–7 days, and the late neonatal
period 8–56 days after delivery (16).
A stillbirth was defined as the death of a fetus with birth
weight ≥0.5 kg or estimated gestation ≥22 weeks (20). Based
on clinical assessment, stillbirths were categorized as macerated
if the stillborn had any of the following skin changes: slipping
skin, bullae formation or desquamation (21). A stillbirth was
considered a fresh stillbirth if the skin changes for maceration
were absent (21). A congenital malformation was considered
“major” if it was life threatening or required surgical correction.
Low birth weight was defined as birth weight of <2.5 kilograms
(20). If a child had more than one diagnosis during admission,
only the main diagnosis was considered in the analysis (15, 16).
Rates of stillbirths were calculated as the number of deaths per
1,000 births.Mortality rates as the number of deaths per 1,000 live
births. Perinatal mortality rate (PMR) was calculated as number
of stillbirths and deaths in the first week of life (early neonatal
period) per 1,000 births (19).
To calculate odds ratios (OR) and 95% confidence intervals
(CI) to estimate related risk factors to deaths (including
stillbirths) and hospital admissions, we used a logistic regression
analysis. Significance was considered when p < 0.050. However,
variables with p < 0.100 in the univariate analysis and sex
(defined a priori as a potential confounder) were included in the
multivariate analysis.
Ethical Approval
The main trial was approved by the Joint Gambia
Government/MRC Ethics Committee (EC). Written informed
consent was obtained from mothers prior to delivery and
enrolment in the clinical trial during their pregnancy.
RESULTS
Maternal and Newborn Baseline
Characteristics
We recruited 829 women (median age of 25.5; IQR 22.0, 30.0)
who delivered 843 babies. Mandinka (42.8%) was the most
common ethnic group. There were 179 (21.7%) primigravidae
TABLE 1 | Baseline characteristics of mothers (N = 829) and their newborns
(N = 843).







Cesarean section 16 (1.9)
Season of delivery
Rainy season 180 (21.4)
Early dry season 165 (19.6)






















Gestational age in weeks at birth
Pre-term (<37) 473 (56.3)
Term (≥37) 367 (43.7)
Birth weight in grams
Normal (≥2,500) 786 (93.5)
Low(<2,500) 55 (6.5)
Twin
Yes (twin) 28 (3.3)




*Mother age (N = 824), birth weight (N = 841), gestational age (N = 840), Husband’s
occupation (N = 826), Number of wives (N = 804), Number of children (N = 826),
education (N = 822), Occupation (N = 826), ethnicity (N = 823).
(Table 1). No maternal deaths were reported during the 8-
week follow up period. There were 14 (3.3%) twin deliveries
(28 newborns), 55 (6.5%) babies were low birth weight and 10
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FIGURE 1 | Pattern of hospitalization and deaths during the study period (0–56) days.
(1.3%) had major congenital malformations (Table 1). Deliveries
were seasonal with peaks observed from September 2013 to
March 2014.
Stillbirths
Thirteen stillbirths (15.4 per 1,000 births 95% CI 7.1–23.8) were
reported during the study. Nine of these were fresh stillbirths
and the remaining four were macerated stillbirths. The causes
attributed to the fresh stillbirths were poor monitoring of labor
(n = 3), twin gestation (n = 2), poor progression of labor (n =
2), eclampsia (n= 1) and Down syndrome (n= 1). Six out of the
nine fresh stillbirths occurred during night shifts (from 8 p.m. to
8 a.m.).
Neonatal Hospitalizations and Associated
Risk Factors
Out of 829 live-births, 63 children (7.6%) were hospitalized
during the 8-week follow-up period. Seventy-five percent of
hospitalized infants were admitted during the early neonatal
period (Figure 1). Most who were hospitalized had multiple
diagnoses at admission. The most common diagnosis was severe
infection (i.e., sepsis, meningitis and pneumonia) (n = 27),
followed by birth asphyxia (n = 13), jaundice (n = 6), and
low birth weight (n = 5). Nine newborns were hospitalized
with major congenital malformations, and five of these had
congenital malformation as the main diagnosis at admission
(Figure 2A). Four of the nine babies had major congenital heart
defects, three co-existing with Down Syndrome and one baby
diagnosed with talipes equinovarus. Three babies had isolated
talipes equinovarus, one baby had a cleft lip and palate, one had
choanal atresia and one had encephalocele.
During the study period, we observed two clusters of
hospitalizations. One cluster included six cases of clinical sepsis
(27.3% of overall sepsis; none confirmed microbiologically) in
June 2013. The second cluster, between January and April 2014,
included 10 cases of severe birth asphyxias, 76.9 % of total cases
(n= 13) reported in the study.
In the multivariate analysis, low birth weight, major
congenital malformations, twin births and cesarean section
deliveries remained significantly associated with hospitalization
(Table 2).
Neonatal Mortality
Sixteen deaths occurred during the follow up period. Almost
two thirds (62.5%) of these deaths occurred during the early
neonatal period (Figure 1). Only one death occurred after the
first 28 days of life. Overall, perinatal mortality rate (PMR) and
neonatal mortality rate (NMR) were 26.1 (95%CI: 15.3–36.9)
and 19.3 (95%CI 9.9–28.7) per 1,000 live births, respectively.
The distribution of cause-of-death during the neonatal period
is shown in Figure 2B. In the multivariate analysis, major
congenital malformations and twin deliveries were the main risk
factors for neonatal mortality (Table 3).
DISCUSSION
We presented hospital-based data of hospitalization and deaths
during the neonatal period in an urban health facility in Western
Gambia from women without known risk factors due to the
exclusion criteria of the trial. Our results show high rates of
poor neonatal pregnancy outcomes, such as stillbirths, neonatal
hospitalization, and mortality. The causes of perinatal death
varied, but stillbirths, severe clinical infections, birth asphyxia
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FIGURE 2 | (A) Main diagnoses at hospitalization during the study period (0–56) days. (B) Main diagnoses of death during the study period (0–56) days.
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TABLE 2 | Risk factor analysis for hospitalization during the study period (0–56 days) (N = 829 live births).
Hospitalization Univariable Multivariable1
n (%) OR (95%CI) p-value OR (95%CI) p-value
Sex
Male 31 (7.19) 0.653 0.986
Female 32 (8.02) 1.13 (0.67–1.88) 0.99 (0.57–1.75)
Ethnicity
Mandinka 29 (8.43)
Wollof 5 (5.38) 0.62 (0.23–1.64) 0.333
Jola 8 (6.35) 0.74 (0.33–1.66) 0.46
Fula 9 (6.38) 0.74 (0.34–1.61) 0.448
Others 11 (10.38) 1.26 (0.61–2.61) 0.539
Birth weight (gram)
Normal (≥2,500) 50 (6.44) <0.001 2.91 (1.24–6.82) 0.014
Low (<2,500) 13 (24.53) 4.72 (2.37–9.39)
Major Congenital malformation
No 58 (7.13) 21.95 (5.12–94.16) <0.001 24.27 (5.23–112.71) <0.001
Yes 5 (62.5)
Twin
No 52 (6.46) <0.001 <0.001
Yes 11 (44) 11.38 (4.92–26.31) 8.20 (3.00–22.39)
Season of delivery
Rainy season 15 (8.57) 0.378
Early dry 10 (6.06) 0.69 (0.3–1.58) 0.732
Late dry 38 (7.76) 0.9 (0.48–1.67)
Mode of delivery
Vaginal 59 (7.22) 0.005 0.005
Cesarean section 4 (30.77) 5.71 (1.71–19.1) 7.05 (1.80–27.49)
Maternal age in years
=<19 1 (1.52) 0.18 (0.02–1.33) 0.093 0.79 (0.32–1.97) 0.617
20–34 55 (7.83) 1 (reference)
≥35 7 (12.28) 1.65 (0.71–3.81) 0.243 1.79 (0.61–5.24) 0.286
Number of children
1 15 (8.62) 0.743
2–3 26 (7.78) 0.89 (0.46–1.74) 0.489
≥4 21 (6.89) 0.78 (0.39–1.56)
Number of father’s wives
1 44 (7.09) 1 (reference) 0.209
>2 17 (10.0) 1.46 (0.81–2.62)
Father employment
None/Home 3 (7.5) 0.915
UnSkilled 16 (8) 1.07 (0.3–3.87) 0.631
Skilled 20 (5.62) 0.73 (0.21–2.59) 0.698
Business 7 (5.79) 0.76 (0.19–3.08) 0.165
Others 16 (16.84) 2.5 (0.69–9.11)
Mother employed
No 45 (6.56) 1 (reference) 0.009 0.067
Yes 17 (13.39) 2.20 (1.22–3.99) 1.89 (0.96–3.75)
Mother’s education in years
<6 29 (6.32) 0.098
≥6 33 (10.06) 1.66 (0.99–2.79) 0.057 1.66 (0.91–3.02)
Unknown 0 (0) –
1Adjusted for sex, low birth weight, major congenital malformation, twin births, mode of delivery, maternal age, mother education level and occupation.
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TABLE 3 | Risk factors of death during the study period (0–56 days) (N = 829 live births).
Univariable Multivariable1




Male 431 9 (2.1) 1 (reference) 0.727 1 (reference) 0.478
Female 399 7 (1.7) 0.84 (0.31–2.27) 0.68 (0.24–1.96)
Ethnicity
Mandinka 344 9 (2.6) 1 (reference)
Wollof 93 1 (1.1) 0.4 (0.05–3.23) 0.32 (0.07–1.38) 0.394
Jola 126 1 (0.8) 0.3 (0.04–2.37) 0.253
Fula 141 2 (1.4) 0.54 (0.11–2.51) 0.428
Others 106 2 (1.9) 0.72 (0.15–3.37) 0.672
Birth weight (grams)
Normal (≥2,500) 776 13 (1.7) 1 (reference) 0.055 1 (reference) 0.612
Low (<2,500) 53 3 (5.5) 3.52 (0.97–12.76) 1.52 (0.30–7.66)
Major congenital malformation
No 809 13 (1.6) 1 (reference) <0.001 1 (reference) <0.001
Yes 8 3 (37.5) 26.6 (6.18–114.48) 36.15 (7.82–167.04)
Twin
No 805 13 (1.6) 1 (reference) 0.002 1 (reference) 0.008
Yes 25 3 (10.7) 8.31 (2.21–31.25) 8.81 (1.74–44.53)
Season of delivery
Rainy season 175 1 (0.6) 1 (reference)
Early Dry season 165 2 (1.2) 2.13 (0.19–23.77) 0.537




Vaginal 817 16 (1.9) 5.45 (1.06–28.45)
Cesarean section 13 0 (0)
Maternal age
≤19 0 0 (0) –
20–34 702 15 (1.8) 1 (reference)
≥35 57 1 (5.2) 2.94 (0.81–10.65) 0.100
Number of children
1 174 2 (1.1) 1 (reference)
2–3 334 5 (1.5) 1.31 (0.25–6.81) 0.750
≥4 305 8 (2.6) 2.32 (0.49–11.03)1.08 (0.42–2.75) 0.29
Mother employed?
No 686 12 (1.7) 1 (reference) 0.639
Yes 127 3 (2.3) 1.35 (0.38–4.88)
Mother’s education in yrs
<6 459 7 (1.5) 1 (reference) 0.36
≥6 328 8 (2.4) 1.61 (0.58–4.5)
Unknown 22 0 (0) –
1Adjusted for sex, low birth weight, major congenital malformation, and twin births.
and major congenital malformations were the most common;
often, these conditions could have been prevented or mitigated
by early identification and preventative measures. However, the
busy public urban health facility where the study took place
lackedmaterial resources, skilled capacity, and space to effectively
manage deliveries. Conversely, there were no maternal deaths
out of the 829 women in the study, which, when considered
against the mortality rate previously described in rural Gambia
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(461 per 100,000 live births) (22), four deaths would have
been anticipated.
Stillbirths represented approximately half of all deaths
observed in the study; most of the observed cases were
fresh stillbirths. The number of macerated stillbirths is likely
underestimated as confirmed intra-uterine fetal death was an
exclusion criterion for women prior to recruitment in the
trial (16). The facility also lacked the capacity to determine if
any of these cases had an underlying congenital malformation,
prenatally. Most stillbirths reported during the trial occurred
during night shifts when deliveries were attended to by fewer
trained and skilled staff e.g., non-midwife staff or trainee
nursing students on training placements. Therefore, this high
number of fresh stillbirths was at least in part attributable to
delivery attendance by non-skilled health care staff, poor labor
monitoring and delay in early diagnosis of obstetric emergencies,
as well as late referral for emergency obstetric care (23). Despite
the high rate of stillbirths reported in this study, this rate has
significantly decreased compared to results from a hospital-based
study conducted in The Gambia in 1988. Late referrals were a
main risk factor for stillbirths in the former study, indicating that
some gaps in the health system have remained problematic for
several decades (23).
Two clusters of hospitalizations, one of birth asphyxia and the
other of neonatal sepsis, further demonstrate the impact of gaps
in the health system on poor pregnancy outcomes. Birth asphyxia
was the second most common cause of hospitalization and
neonatal deaths. Severe birth asphyxia may be prevented by early
identification; however, delay in detection and subsequent non-
skilled birth attendance often culminated in serious intrapartum
events that result in cases of birth asphyxia. Almost 80% of
these cases observed during this trial occurred during this cluster,
which coincided with the absence of an experienced night-shift
midwife during peak months of delivery. This indicates that the
absence of trained healthcare personnel may have had an impact
on outcomes for these cases, a common situation in many health
facilities across The Gambia and SSA (24, 25). The sepsis cluster
coincided with a dysfunctional autoclave used for sterilization of
delivery kits, as well as poor hygienic states in both the delivery
and post-natal wards. During this instance, six cases of neonatal
sepsis were reported within 4 weeks. When the autoclave was
identified as dysfunctional and was repaired, along with the
introduction of a weekly general ward cleaning exercise, the cases
of neonatal sepsis drastically reduced.
Multiple pregnancy was also a risk factor for poor pregnancy
outcomes; twins accounted for 18.8% of neonatal deaths in this
study, and 22.2% of fresh stillbirths. These data are consistent
with a community-based analysis conducted as part of the Health
and Demographic Surveillance System in rural Gambia where
∼1 in 8 neonatal deaths occurred among twins (9). To improve
outcomes for multiple pregnancies, early detection and referral
is vital; again, this indicates the importance of attendance to
deliveries by skilled healthcare personnel.
Major congenital malformations was another risk factor
for both hospitalization and mortality, representing 18.8% of
our neonatal deaths. According to estimates generated by the
WHO and Maternal and Child Epidemiology Estimation Group
(MCEE) 2018, congenital abnormalities was the fourth leading
cause of neonatal deaths in The Gambia in 2015 accounting
for up to 10% all neonatal deaths (26). The higher prevalence
found among fatalities in our study may be linked to the
study design, where all our participants were evaluated by a
research clinician hours after birth and therefore any congenital
malformations were more likely to be detected. Also, the high
burden of major congenital malformations in The Gambia is not
surprising given the high frequency of consanguineous marriages
(∼30% among first-cousin marriages) (17), a described risk
factor in countries where this practice is common (27). In a
retrospective study in Tunisia, where rates of consanguinity
are higher than in The Gambia (40–49%) (28), almost half of
autopsies showed a congenital malformation in the newborn,
and parental consanguinity was identified as a main risk factor
(29). Prospective studies conducted in high-income countries
have also shown that congenital malformations are a major cause
of stillbirth and neonatal mortality; it is reasonable to assume
that congenital malformations cause an even greater number
of stillbirths and neonatal deaths in low-income settings like
The Gambia (30) due to the lack of necessary equipment and
capacity available to detect these malformations, combined with
limited access to preventive care, skilled healthcare workers, and
emergency obstetric facilities (24).
A recent hospital-based neonatal mortality audit conducted in
the main referral hospital in The Gambia, showed that low birth
weight was an independent predictor of neonatal death (31). We
found the same association for hospitalization although the trend
is not significant for mortality, probably due to lack of power or
the correlation between low-birth weight and twin births.
Our health facility-based study complements previous data
generated from community-based studies as more than 80% of
deliveries in The Gambia take place in health facilities (14).
In addition, ours uses data that was collected prospectively
in contrast to former retrospective reviews of inpatient data
(23, 31). The main limitation of our analysis, however, is that
it uses data from a single health facility which may not be
representative of all facilities in The Gambia as wide variability
between health facilities have been described in the region
(7, 14, 32). On the other hand, the care for the participants
in this study was likely above national standards. The intense
follow-up of study participants probably led to earlier detection,
improved clinical care and increased hospitalization rates; but
might have reduced mortality and skewed the diagnosis as most
deaths due to infections that were more promptly diagnosed and
quickly treated probably improved outcome. After labor, each
participant was discharged from the health facility by a clinician
or pediatrician, which should have resulted in more accurate
diagnoses of congenital malformations which may otherwise
have been missed. The study criteria also potentially affected
outcomes: the recruited women excluded those with high risk
pregnancies, as well as participants with chronic conditions who
required on-going medication. For instance, even the high rate
of stillbirths and neonatal deaths reported were approximately
half the rates described by United Nations and WHO 2017
countdown to 2030 progress report (24 per 1,000 total births and
28 per 1,000 live births, respectively, in the year 2015) (26). The
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results of this analysis may further underestimate overall rates of
severe morbidity and mortality due to severe infections; half of
the newborns in the study were born to mothers who received
azithromycin during labor. We observed statistically significant
differences between trial arms in less-severe outcomes, although
the trial was not designed or powered to detect differences in
mortality. Additionally, in the analysis of arms comparison, we
found that deaths in the intervention arm but not in the placebo
arm were associated with an underlying condition (15).
In conclusion, the results of this analysis indicate rates of
neonatal hospitalization and mortality in The Gambia are still
high. Although vertical interventions may reduce specific causes
of death, improving weak health systems is a critical factor in
widening the impact of such interventions to reach targets set
in the Sustainable Development Goal 3.2. There should also be
emphasis on investigating ways to reduce complications during
labor which result in fresh stillbirth and severe birth asphyxia.
Initiatives must be undertaken to train healthcare workers on the
importance of preventive care including infection control and
early identification of risk factors. Though vertical interventions
present opportunities for impact on specific causes of neonatal
morbidity and mortality, the quality of a health system may
ultimately determine outcomes for this vulnerable population;
further investigations are warranted to identify high-risk gaps in
health systems during delivery and postnatal care.
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